Nuedexta Oral Capsule 20-10Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Nuedexta: Oral capsule (20-10mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_17018.JPG
Nuedexta 20mg-10mg Capsule
Avanir Pharmaceuticals
Pill Identification: DMQ 20-10 

What is this Medicine?

DEXTROMETHORPHAN; QUINIDINE (dex troe meth OR fan; KWIN i deen) is a combination of two medicines used to treat pseudobulbar affect (PBA), a condition that causes uncontrollable, sudden, and frequent episodes of laughing and/or crying.

CVS Pharmacy Patient Statistics for Nuedexta: Oral capsule(20-10mg)
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage By Strength
In-Depth Information

Nuedexta 20mg-10mg Capsule

NDC: 645970301
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Pseudobulbar Affect

Storage Information
Protect from light
Protect from moisture
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Nuedexta 20mg-10mg Capsule
Drug Image file DrugItem_17018.JPG
Avanir Pharmaceuticals
Pill Identification: DMQ 20-10 
Shape: capsule
Color: red

Reported Side Effects for Nuedexta 20mg-10mg Capsule

Muscle Cramps Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Stomach Pain Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Gas Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Flu Incidence:
4.0%*
Severity: MILD
Onset: DELAYED
Infection Incidence:
4.0%*
Severity: MILD
Onset: DELAYED
Cough Incidence:
5.0%*
Severity: MILD
Onset: DELAYED
Weakness Incidence:
5.0%*
Severity: MILD
Onset: DELAYED
Vomiting Incidence:
5.0%*
Severity: MILD
Onset: EARLY
Fluid Retention Incidence:
5.0%*
Severity: MODERATE
Onset: DELAYED
Lightheadedness Incidence:
10.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
13.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Nuedexta 20mg-10mg Capsule

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Major Lifestyle Interaction
Grapefruit juice and Nuedexta Capsule(Quinidine Sulfate)
Grapefruit juice and Quinidine(Quinidine Sulfate)
Side effects from Quinidine may get worse if you take Grapefruit juice. Do not take Quinidine and Grapefruit juice together. Grapefruit juice can raise the level of Quinidine in the blood, which could increase the chance of side effects from Quinidine such as nausea/vomiting, a slow heart rate, or dizziness. Contact your prescriber immediately if you experience fainting or falling spells, palpitations, shortness of breath, or a change in your usual heart beat (fast, slow, or irregular heart beat) while taking Quinidine. Discuss with your health care provider why you should avoid grapefruit juice intake when taking Quinidine.
Minor Lifestyle Interaction
Grapefruit juice and Nuedexta Capsule(Dextromethorphan Hydrobromide)
Grapefruit juice and Dextromethorphan(Dextromethorphan Hydrobromide)
Grapefruit juice may increase the actions of Dextromethorphan. Side effects from the Dextromethorphan may get worse if you drink grapefruit juice. It may be best to avoid drinking grapefruit juice while you are taking Dextromethorphan.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More